2 Einträge von mit respiratory risk
clinicalodyssey.com
Datum der Indexierung 03.05.2024 22:10:46
Subdomain:
extern (outbound) Link/Domain 2 in .clinicalodyssey.com
intern (inbound) Link/Domain .clinicalodyssey.com
Alle Links in alle Links in .clinicalodyssey.com
Kombination Keywords measles organ | with joyworks | clinical systems | virus subscribe | your contact | vaccines transmission | dose disease | first administered | about areas | odyssey months |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
respiratory and neurological complications. Epidemiology Measles occurs worldwide, but is predominantly seen areas with low vaccination rates—particularly low-resource settings. In high-resource settings, outbreaks occur in areas where vaccination up risk of measles mortality remains high, the first routine dose should be given earlier—at 9 months of age. MMR vaccines should not be administered to pregnant women and severely immunosuppressed persons. Introduction Measles is a
Text Inhalt Text aus URL
Log Metriken 12459
Subdomain:
extern (outbound) Link/Domain 2 in .clinicalodyssey.com
intern (inbound) Link/Domain .clinicalodyssey.com
Alle Links in alle Links in .clinicalodyssey.com
Kombination Keywords measles organ | with joyworks | clinical systems | virus subscribe | your contact | vaccines transmission | dose disease | first administered | about areas | odyssey months |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
respiratory and neurological complications. Epidemiology Measles occurs worldwide, but is predominantly seen areas with low vaccination rates—particularly low-resource settings. In high-resource settings, outbreaks occur in areas where vaccination up risk of measles mortality remains high, the first routine dose should be given earlier—at 9 months of age. MMR vaccines should not be administered to pregnant women and severely immunosuppressed persons. Introduction Measles is a
Text Inhalt Text aus URL
Log Metriken 12459
www.cslbehring.ch
Datum der Indexierung 04.10.2024 23:30:40
erkannte Namen Grant Provider | Asia Pacific |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies more | behring areas | with health | that investigator-initiated | disease including | your research | products quality | investigator diseases | initiated patients | application clinical |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Respiratory Cardiovascular & Metabolic Transplant The CSL Behring IIS program is open to physicians, researchers and institutions interested in conducting their own research. We receive many requests for support and carefully evaluate each one with p risk for GvHD Use of Alpha-1 Antitrypsin to prevent/ameliorate acute GvHD through mechanistic and early/pilot clinical studies Studies aimed at defining and understanding the immunomodulatory effects of Alpha-1 Antitrypsin Ischemi
Text Inhalt Text aus URL
Log Metriken 86097
erkannte Namen Grant Provider | Asia Pacific |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords studies more | behring areas | with health | that investigator-initiated | disease including | your research | products quality | investigator diseases | initiated patients | application clinical |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Respiratory Cardiovascular & Metabolic Transplant The CSL Behring IIS program is open to physicians, researchers and institutions interested in conducting their own research. We receive many requests for support and carefully evaluate each one with p risk for GvHD Use of Alpha-1 Antitrypsin to prevent/ameliorate acute GvHD through mechanistic and early/pilot clinical studies Studies aimed at defining and understanding the immunomodulatory effects of Alpha-1 Antitrypsin Ischemi
Text Inhalt Text aus URL
Log Metriken 86097